Drug Patents owned by Dexcel Pharma

1. List of Esomeprazole Magnesium drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10835488 DEXCEL PHARMA Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(13 years from now)

US10076494 DEXCEL PHARMA Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(13 years from now)

Drugs and Companies using ESOMEPRAZOLE MAGNESIUM ingredient

Market Authorisation Date: 20 October, 2020

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

More Information on Dosage

ESOMEPRAZOLE MAGNESIUM family patents

3

United States

2

European Union

1

Israel

1

Australia

2. List of Hemady drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10537585 DEXCEL PHARMA Compositions comprising dexamethasone
Dec, 2037

(14 years from now)

US11304961 DEXCEL PHARMA Compositions comprising dexamethasone
Dec, 2037

(14 years from now)

Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Oct 3, 2026

Drugs and Companies using DEXAMETHASONE ingredient

Market Authorisation Date: 03 October, 2019

Treatment: A method of treating adults with multiple myeloma using dexamethasone in combination with an anti-myeloma product

Dosage: TABLET;ORAL

More Information on Dosage

HEMADY family patents

2

United States

1

Israel

3. List of Lansoprazole drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11077055 DEXCEL PHARMA Orally disintegrating compositions
Apr, 2036

(13 years from now)

Drugs and Companies using LANSOPRAZOLE ingredient

Market Authorisation Date: 07 June, 2016

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

More Information on Dosage

LANSOPRAZOLE family patents

4

United States

2

Israel

1

European Union

4. List of Omeprazole drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9023391 DEXCEL PHARMA Stable benzimidazole formulation
Aug, 2025

(2 years from now)

US10835488 DEXCEL PHARMA Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(13 years from now)

US10076494 DEXCEL PHARMA Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(13 years from now)

Drugs and Companies using OMEPRAZOLE ingredient

Market Authorisation Date: 04 December, 2007

Treatment: NA

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage

OMEPRAZOLE family patents

8

United States

4

Israel

3

European Union

2

Australia

1

Germany

1

Austria

1

Spain

1

Canada

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in